Tag Sharett Institute of Oncology

24 Jul

Hadassah Cancer Research Institute: Groundbreaking Advance in Personalised Cancer Care

Hadassah Cancer Research Institute (HCRI), a leading force in advancing cancer treatments, unveils a significant breakthrough in personalised cancer care.   This research, published in the esteemed journal Cell Reports Medicine (June 11, 2024), introduces MESiCA, a novel machine learning model poised to revolutionise cancer diagnosis and treatment.   Professor Michal Lotem, Head of HCRI […]

READ MORE

16 May

Hadassah Clinical Trial of Proton Radiation Treatment For Cancer Patients

For the first time in Israel, Hadassah Medical Organization (HMO) working in collaboration with Israeli company P-Cure, is now able to provide ground-breaking experimental proton radiation treatment to cancer patients.   This treatment is more precise and efficient, safer, with fewer side effects than any other treatment available. In the past, Israeli patients who wanted […]

READ MORE

8 Mar

Hadassah’s New Gene Targeting Tool Can Improve Cancer Treatment Outcomes for Patients

Hadassah Cancer Research Institute at the Hadassah University Hospital in Jerusalem, announced last month that researchers have designed a genomic analysis tool for cancer patients that enables advanced selection of drugs targeting schemes for cancer genes, opening the door to improved personalised medicine in cancer treatment.   The science behind this breakthrough tool is a […]

READ MORE

5 Sep

World First at Hadassah:

An artificial-intelligence algorithm to identify a group of “point mutations” that cause cancer in TP53 – a gene involved in about half of all cancerous tumours – has been developed by a group of researchers at Hadassah-University Hospital in Jerusalem. Their discovery has aroused much interest among doctors and scientists around the world.   The […]

READ MORE

16 Feb

Predictive-AI Algorithm Successfully Identifies Common Cancerous Gene Mutations at Hadassah Cancer Research Institute

Breakthrough research at Hadassah identifies all possible cancer-causing mutations of a key gene (TP53) found in 50% of tumours. The Hadassah Cancer Research Institute at the Hadassah University Medical Centre in Jerusalem, announced today that using artificial intelligence (AI), researchers have developed, an algorithm to identify, with an unprecedented 96.5% level of accuracy, all possible deleterious […]

READ MORE

14 Oct

Battling Cancer at Hadassah

Hadassah’s 44-year-old Sharett Institute of Oncology at Hadassah’s Ein Kerem campus has set the benchmark for preventing, treating and researching cancer in Israel. “Its legacy of cancer care is very strong,” affirmed the Sharett Institute’s new director, Dr. Aron Popovtzer. “We’ve seen a 30 percent increase in patients this past year alone,” said Dr. Popovtzer, […]

READ MORE
Subscribe

Join our digital newsletter to stay in touch with the latest news from Hadassah UK